JPRN-UMIN000033185已完成未知
The effects of bifidobacterium lactis strain NT and effects of addition to galacto-oligosaccharide on defecation frequency in healthy subjects with low defecation frequency: a randomized, double-blind, placebo-controled, parallel-group trial - The effects of bifidobacterium lactis strain NT and effects of addition to galacto-oligosaccharide on defecation frequency in healthy subjects with low defecation frequency: a randomized, double-blind, placebo-controled, parallel-group trial
Second Lecture of Internal Medicine, Wakayama Medical University School of Medicine0 个研究点目标入组 69 人开始时间: 2018年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 69
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subjects diagnosed with constipation or subjects who fit the Rome IV criteria in the interview 2. Subjects who have the history of organic disease in the gastrointestinal tract in the past and present 3. Subjects who diagnosed as kidney disease 4. Subjects who diagnosed as diabetes 5. Subjects who diagnosed with hypothyroidism 6. Subjects who diagnosed with inflammatory disease 7. Subjects who diagnosed with neurological or psychiatric disease 8. Subjects who took antibiotics or probiotics within the past 1 month including present 9. Subjects who take the drugs inducing chronic constipation 10. Subjects who use biological drugs and steroids 11. Subject who take the foods containing lactic acid bacteria or bifidus bacteria routinely 12. Subject who take the health food for constipation improvement routinely 13. Subjects who have a history of allergy to the foods containing lactobacillus or bifidus bacteria 14. Subjects who participating in other clinical tests about food containing probiotics, or who have not been past one month since participation 15. Subjects who cannot stop the use of constipation drugs and that of foods for constipation improvement during the research period 16. Subjects who will travel overseas during the research period 17. Subjects who investigator judge not suitable to participate in the trial
研究者
相似试验
已完成
不适用
Effects of Bifidobacterium animalis subsp. lactis BB-12 intake on bowel movement and intestinal environment: a systematic review with meta-analysisJPRN-UMIN000038611KAGOME CO., LTD.100
已完成
不适用
Effects of Lactic Acid Bacteria and Bifidobacterium-containing Supplements on Intestinal FloraJPRN-UMIN000036843Japan clinical trial assosiation21
尚未招募
3 期
Evaluation of Bifidobacterium Animalis Spp. Lactis oral suspension effect on crying/fussing time and changes of gut microbiota in formula-fed infants with colicInfantile colic, probiotic, intestinal dysbiosis, microbiota, bifidobacterium lactis.R10.4IRCT20170201032346N3Ramsar Campus, Mazandaran University of Medical Sciences50
尚未招募
不适用
The impact of lactobacillus bifidus and soluble dietary fiber on bowel movement and intestinal flora in morbidly obese patients undergoing bariatric surgeryobesityJPRN-UMIN000027528Yotsuya Medical Cube30
已完成
不适用
A study to investigate the effects of Bifidobacteria on stress relief: a randomized, double-blind, placebo-controlled, parallel-group comparative study.oneJPRN-UMIN000028941Matsumoto Junior College120
